Endurant Capital Management Lp increased its stake in Ocular Therapeutix Inc (OCUL) by 207.71% based on its latest 2019Q1 regulatory filing with the SEC. Endurant Capital Management Lp bought 483,397 shares as the company’s stock declined 1.91% while stock markets rallied. The institutional investor held 716,124 shares of the health care company at the end…